FDA clearance for Phase I/II using hESC’s to treat Macular Degeneration, Advanced Cell Technology (ACTC.OB)
November 22nd, 2010
No comments
The US FDA has lifted the clinical hold and cleared ACT’s Investigational New Drug (IND) application to (immediately) initiate a Phase I/II multicenter study Read more…
